(Q46829214)

25 December 2017

title

Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients (English)

1 reference

25 December 2017

author name string

Wendy Chrapko

1

1 reference

25 December 2017

Paul Jurasz

2

1 reference

25 December 2017

Marek W Radomski

3

1 reference

25 December 2017

Stephen L Archer

4

1 reference

25 December 2017

Stephen C Newman

5

1 reference

25 December 2017

Glen Baker

6

1 reference

25 December 2017

Nathalie Lara

7

1 reference

25 December 2017

Jean-Michel Le Mellédo

8

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

25 December 2017

published in

Neuropsychopharmacology

1 reference

25 December 2017

volume

31

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

1286-1293

1 reference

25 December 2017

Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Heavy and light cigarette smokers have similar dysfunction of endothelial vasoregulatory activity: an in vivo and in vitro correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Endothelial dysfunction: a marker of atherosclerotic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Pathogenetic concepts of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Endothelial dysfunction in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Detection of endothelial dysfunction with brachial artery ultrasound scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Nitric oxide released from activated platelets inhibits platelet recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Sertraline treatment of major depression in patients with acute MI or unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Depression and cardiovascular disease: mechanisms of interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Paroxetine-Induced Increase in Metabolic End Products of Nitric Oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Endothelium and the lipid metabolism: the current understanding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Platelet reactivity in depressed patients treated with paroxetine: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Inhibitory effect of glucocorticoid on coronary artery endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Cardiovascular effects of fluoxetine in depressed patients with heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Treating depression in patients with ischaemic heart disease: which agents are best to use and to avoid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Epidemiology of comorbid coronary artery disease and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Primary endothelial dysfunction: atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Smoking a single cigarette rapidly reduces combined concentrations of nitrate and nitrite and concentrations of antioxidants in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Nitric oxide as a challenge for the clinical chemistry laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

Measurement of nitric oxide in biological models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Impaired Platelet Production of Nitric Oxide Predicts Presence of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Increased cholesterol levels during paroxetine administration in healthy men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Cortisol inhibits cholinergic vasodilation in the human forearm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

An improved method for washing of human platelets with prostacyclin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Abnormal brachial artery flow-mediated vasodilation in young adults with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Treatment of depression in patients with heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300961

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300961

1 reference

25 December 2017

Dimensions Publication ID

1028699320

0 references

1 reference

25 December 2017